FHIR Engine
FHIREngine Inc. is a Boston-based healthcare IT company that sells ONCOSure, an oncology-specific clinical decision support platform integrating NCG, NCCN, AJCC, and ICMR guidelines with SNOMED CT and HL7-FHIR interoperability for hospitals, oncology providers, and EMR vendors.
- Company typePrivate
- Founded2021
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What FHIR Engine does
FHIR Engine (FHIREngine Inc.) is a privately held U.S. healthcare IT company founded in 2021 and headquartered in Boston, MA, with a wholly-owned India subsidiary operating offices in Bengaluru, Hyderabad, Pune, and Mumbai. The company sells ONCOSure™, an oncology-specific clinical decision support (CDS) platform that helps hospitals, oncology providers, and EMR vendors create and personalize treatment plans based on guidelines from NCG, NCCN, AJCC, and ICMR. The platform is preconfigured with a SNOMED CT terminology server, integrated prior authorization capabilities, and AI-based analytics for biomarker recommendations, and integrates into EMR systems via SMART on FHIR.
The underlying technology stack is HL7-FHIR based, augmented with X12 EDI (278/275 for prior authorization and 270/271 for eligibility) and SNOMED CT terminology services, positioning the product for interoperability mandates including FHIR R4/R5 and TEFCA. Core go-to-market combines direct enterprise sales to hospitals, OEM/embedded distribution through EMR vendors using the SMART on FHIR app, and a channel partnership with Amoeba Business Solutions in India. Revenue is generated through platform licensing, subscription-based SMART on FHIR app distribution, and professional services for implementation.
The company has no disclosed funding beyond a single ~$792,915 round in March 2025, no public revenue, 1–10 employees, no disclosed management team, and no patents or formal awards. Customer logos are predominantly small and mid-market oncology providers and clinics (e.g., Lifepoint Hospital, Mauli Hospital, Cancer Center of Colorado, Geetai Hospital, Kotlwar Clinic, Pi Cancer Care), suggesting an early commercial stage with limited enterprise penetration.
FHIR Engine firmographics
Firmographics- Name
- FHIR Engine
- Legal name
- FHIREngine Inc.
- Website
- https://fhirengineinc.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- FHIREngine Inc. is a Boston-based healthcare IT company that sells ONCOSure, an oncology-specific clinical decision support platform integrating NCG, NCCN, AJCC, and ICMR guidelines with SNOMED CT and HL7-FHIR interoperability for hospitals, oncology providers, and EMR vendors.
- Ownership category
- akta.pro rank
FHIR Engine industry classification
Industry- Product category
- Healthcare IT — Clinical Decision Support
- NAICS
- Computer Systems Design Services (541512), Computer Systems Design and Related Services (54151), Other Computer Related Services (541519)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)
- akta.pro secondary industries
- Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE), Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA), FHIR/HL7 Data Repositories & Canonical Data Models (HLACAIAI), Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery) (HLACAMAL)
Keywords
Where FHIR Engine is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
FHIR Engine business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Healthcare IT Platform Licensing: Licensing of ONCOSure™ oncology clinical decision support platform to hospitals and EMR vendors. Platform includes SNOMED CT terminology server, oncology guidelines, AI analytics, and prior authorization modules.
- SMART on FHIR App Distribution: Distribution of SMART on FHIR applications integrated into EMR systems, providing clinical decision support capabilities to healthcare providers.
- Professional Services: Implementation and deployment services for healthcare organizations seeking to integrate FHIREngine products into their existing systems, helping payers and providers streamline operations.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
FHIR Engine product offering
Product offeringCore offering
FHIR Engine develops ONCOSure™, an oncology-specific precision clinical decision support (CDS) platform that helps oncology providers and EMRs create and personalize treatment plans based on NCG, NCCN, AJCC, and ICMR guidelines. The platform is preconfigured with a full SNOMED CT terminology server, standard oncology guidelines, AI-based analytics, and an integrated prior authorization module, and is delivered via HL7-FHIR and SMART on FHIR standards for interoperability.
Product overview
FHIREngine Inc. is a US-based Healthcare IT company with a subsidiary in India that specializes in solutions for payers and providers. The company's portfolio centers on ONCOSure, an oncology-specific clinical decision support platform that integrates with EMR systems via SMART on FHIR. FHIREngine's products utilize HL7-FHIR, X12 EDI (278/275 and 270/271), and SNOMED CT-based architecture to help healthcare organizations streamline operations and reduce administrative burden. The ONCOSure platform targets both hospital systems (for automated clinical pathways and biomarker recommendations) and EMR vendors (for embedded decision support capabilities).
Differentiator
Problem solved
Functional benefit
Brands
- ONCOSure™: Oncology-specific precision clinical decision support (CDS) platform that helps oncology providers and EMRs create and personalize treatment plans based on guidelines recommended by NCG, NCCN, AJCC, ICMR. Comes preconfigured with SNOMED CT terminology server, standard oncology guidelines, advanced analytics, and integrated prior authorization module.
Products and services
- ONCOSure™
Quantifiable outcome
- Reduced treatment costs through evidence-based protocols and prior authorization automation
- +2 more outcomes
Companies that use FHIR Engine
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
FHIR Engine technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature7 records
FHIR Engine partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, flagship and minor.
- American Joint Committee on Cancer (AJCC)coreAJCC is a clinical partner of FHIREngine, providing authoritative cancer staging guidelines that are integrated into the ONCOSure platform. The partnership enables evidence-based tumor classification using AJCC standards within the clinical decision support system.
- National Comprehensive Cancer Network (NCCN)coreNCCN is a clinical partner providing biomarker guidelines and oncology treatment standards for the ONCOSure platform. The partnership ensures access to comprehensive cancer care standards and clinical practice guidelines embedded in the CDS system.
- American Medical Association (AMA)flagshipAMA is a clinical partner providing medical standards and guidelines for oncology care integration. The partnership enhances credibility and ensures alignment with American medical standards for clinical decision support.
- Roch FoundationminorRoch Foundation is listed as an associate partner, providing potential funding or strategic alignment with oncology research and treatment initiatives.
- Amoeba Business SolutionscoreAmoeba Business Solutions is a channel partner distributing FHIREngine products in the Indian market, particularly in India where FHIREngine has subsidiary offices in Bengaluru, Hyderabad, Pune, and Mumbai. The partnership expands market reach for ONCOSure in the Asia-Pacific region.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
FHIR Engine competitors and assessment
Company assessmentDirect peers
- Flatiron Health: Oncology-specific data and clinical decision support platform (acquired by Roche) serving hospitals, academic centers and life sciences companies. Closest direct competitor to ONCOSure in oncology-focused CDS, real-world evidence and EMR-embedded workflows.
- Tempus Labs: Precision medicine company combining genomic sequencing, clinical data and AI to support oncology treatment decisions. Competes with FHIR Engine on AI-driven oncology decision support, biomarker recommendations and integration into provider workflows.
- Syapse: Precision oncology platform used by health systems to support molecular tumor boards and evidence-based treatment selection. Direct overlap with ONCOSure's guideline-driven, biomarker-aware oncology CDS use case inside large provider networks.
- CancerIQ: Oncology risk-assessment and clinical decision support platform embedded in EHRs to manage hereditary cancer programs and precision treatment. Comparable as a specialty oncology CDS layer that lives inside provider EMR environments.
- Navigating Cancer: Oncology patient management and care-pathway platform for community oncology practices, including treatment plan management and symptom monitoring. Overlaps with ONCOSure on standardized oncology pathways and treatment-protocol decision support.
- NantHealth: Provider of evidence-based oncology clinical decision support (e.g., eviti) integrated with payer benefits and treatment regimens. Directly comparable to ONCOSure on payer-aligned, regimen-level oncology decision support and prior authorization workflows.
Emerging players
- Redox: FHIR-native healthcare integration platform that connects EHRs to digital health applications. Comparable as an enabler of SMART on FHIR app distribution and the EMR-embedded channel that ONCOSure also relies on for go-to-market.
Broad incumbents
- Epic Systems: Dominant U.S. EHR vendor with built-in oncology decision support (Beacon) and deep FHIR/SMART app ecosystem. The most powerful channel and competitive threat to ONCOSure's strategy of embedding oncology CDS into the EMR.
- Oracle Health (Cerner): Major U.S. EHR platform (formerly Cerner) with embedded clinical decision support and an active FHIR/ interoperability roadmap. A broad incumbent whose oncology CDS roadmap competes with niche vendors like FHIR Engine.
- Philips Oncology Solutions: Large medtech and oncology informatics portfolio (including radiation oncology and tumor board solutions) with provider- and payer-facing decision support. Comparable as a broader incumbent offering oncology clinical workflows and pathway tooling to hospitals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
FHIR Engine financial estimates
Financial estimateRevenue estimate
Valuation estimate
FHIR Engine leadership team
Management profileNumber of profiles
FHIR Engine subsidiaries and ownership
Company hierarchySubsidiaries1 record
FHIR Engine funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FHIR Engine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FHIR Engine
What does FHIR Engine do?
FHIR Engine develops ONCOSure™, an oncology-specific precision clinical decision support (CDS) platform that helps oncology providers and EMRs create and personalize treatment plans based on NCG, NCCN, AJCC, and ICMR guidelines. The platform is preconfigured with a full SNOMED CT terminology server, standard oncology guidelines, AI-based analytics, and an integrated prior authorization module, and is delivered via HL7-FHIR and SMART on FHIR standards for interoperability.
Is FHIR Engine a public or private company?
FHIR Engine is a private company. It is classified as unknown and is currently operating.
When was FHIR Engine founded?
FHIR Engine was founded in 2021. It employs 1 to 10 people.
Where is FHIR Engine based?
FHIR Engine is headquartered in Boston, United States, in the North America region.
How does FHIR Engine make money?
Three revenue lines are on record. Healthcare IT Platform Licensing is the primary driver. The others are SMART on FHIR App Distribution and professional Services.
Who are FHIR Engine's main competitors?
Direct peers on record are Flatiron Health, Tempus Labs, Syapse, CancerIQ, Navigating Cancer and NantHealth. Redox is listed as an emerging player. Broad incumbents are Epic Systems, Oracle Health (Cerner) and Philips Oncology Solutions.
Does FHIR Engine have an API?
No public API is recorded for FHIR Engine.
What industry is FHIR Engine in?
FHIR Engine's product category is Healthcare IT — Clinical Decision Support. Its primary akta.pro industry code is HLACAGAH, Oncology Pathways & Precision Medicine Decision Support, with a secondary code of HLAAANAE, Clinical Decision Support & Workflow Integration (EHR/oncology systems). Its NAICS code is 541512 and its SIC code is 7372.